Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Packerfan666on Dec 28, 2018 12:05pm
142 Views
Post# 29164778

I was angry too. But

I was angry too. But Let’s start a conversation about what has changed? Why is no one acknowledging the great results, everyone is complaining about share price. Hey no one is more frustrated than me. But look at facts, we had great results, the 150 dose is up next which is the exact dose used in all of the phase 2A trials. So we should expect great results again. Phase 3 will begin at end of the year. The stock price sucks cause of timing, time of year, and bad financings by management. I will give you all that. But selling at less than 6 cents even just for the patents is comical. No matter how mad I have been , I never thought to sell at anything less than 50 cents. Look at SIC they hadn’t amazing results from Drilling and they dropped, this is end of year market right now. Let’s Ben patient and see what comes in January. IMO
Bullboard Posts